参芪益肝汤对乙肝肝纤维化患者治疗前后肝功能及肝纤维化指标的影响及意义
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

山东省医药卫生科技发展计划项目(2011BJYB25)


Effects and Significance of Shenqi Yigan Decoction on Liver Function and Index of Hepatic Fibrosis in Patients with Hepatitis B Fibrosis before and after Treatment
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨参芪益肝汤治疗乙肝肝纤维化的疗效,分析治疗前后患者肝功能及肝纤维化指标的变化及意义。方法:选取2014年3月至2015年12月日照市中医医院收治的乙肝肝纤维化患者102例作为研究对象,按照随机数字表法分为对照组和观察组,每组51例。对照组给予常规护肝药物进行治疗,观察组在对照组基础上加用参芪益肝汤进行治疗,1个疗程为3个月,2组患者均连续治疗2个疗程。统计2组患者临床疗效,治疗前后症状及体征改善情况,比较治疗前后2组患者超声影像学检测指标;检测并比较治疗前后2组患者血清肝功能及肝纤维化指标的变化。结果:治疗后,观察组总有效率为8431%;对照组总有效率为6863%;观察组总有效率明显高于对照组(P<005)。与治疗前比较,治疗后2组患者肝区胀或痛、疲倦乏力、食欲不振、大便异常及面色晦暗等症状、体征患者比例均明显降低(P<005或P<001),且观察组除面色晦暗外,其余症状、体征患者比例均显著低于对照组(P<001);与治疗前比较,治疗后2组患者门静脉直径、脾肿指数,血清ALT、AST、TBil、HA、PⅢP、LN水平及观察组Ⅳ-C水平均明显降低,且观察组显著低于对照组(P<005或P<001),观察组右肝斜径明显减小(P<005),而对照组无显著变化(P>005)。结论:参芪益肝汤可显著改善乙肝肝纤维化患者肝功能,抑制肝纤维化,明显改善患者临床症状及体征,疗效显著。

    Abstract:

    To investigate the therapeutic effects of Shenqi Yigan Decoction on hepatitis B fibrosis,and to analyze the changes and significance of liver function and liver fibrosis indexes before and after treatment.Methods:A total of 102 patients with hepatitis B fibrosis admitted to Rizhao Traditional Chinese Medicine Hospital from March 2014 to December 2015 were randomly divided into a control group(n=51)and an observation group(n=51).The control group was treated with routine liver-protecting drugs.The observation group was treated with Shenqi Yigan Decoction on the basis of the control group.One course was 3 months,and both groups were treated for 2 consecutive courses.The clinical efficacy,the improvement of symptoms and signs before and after treatment in the 2 groups was counted.The ultrasound imaging indicators of the 2 groups before and after the treatment were compared.The changes of serum liver function and liver fibrosis indexes before and after treatment were compared between the 2 groups.Results:After treatment,the total effective rate in the observation group was 8431%,and the total effective rate in the control group was 6863%.The total effective rate in the observation group was significantly higher than that in the control group(P<005).Compared with before treatment,the proportion of patients with symptoms and signs such as liver swelling or pain,fatigue,loss of appetite,abnormal stool and dark complexion in the 2 groups decreased significantly after treatment(P<005 or P<001),and the proportion of patients with other symptoms and signs in the observation group was significantly lower than that in the control group(P<001).Compared with before treatment,the diameter of portal vein and spleen indices,serum ALT,AST,TBil,HA,PIII P,LN levels in the 2 groups after treatment and IV-C levels in the observation group were significantly decreased than those in the control group,and the observation group was significantly lower than those in the control group(P<005 or P<001).The right hepatic oblique diameter in the observation group was significantly reduced(P<005),while there was no significant change in the control group(P>005).Conclusion:Shenqi Yigan Decoction can significantly improve liver function,inhibit liver fibrosis and improve clinical symptoms and signs of patients with hepatitis B fibrosis.

    参考文献
    相似文献
    引证文献
引用本文

于收,孙延芬,王佳佳.参芪益肝汤对乙肝肝纤维化患者治疗前后肝功能及肝纤维化指标的影响及意义[J].世界中医药,2019,(08).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2019-02-26
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-09-10
  • 出版日期:
文章二维码